Joint Formulary & PAD

Apomorphine hydrochloride - Parkinson's disease (challenge test)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
BNF SPC
NFD1
Restrictions / Comments :

Documentation

PAD Profile

ChemicalSubstance :
Apomorphine hydrochloride
Indication :
Parkinson's disease (challenge test)
Group Name :
Keywords :
PD
Brand Names Include :
APO-go, Dacepton
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Apomorphine hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Parkinson's disease (challenge test).

Committee Recommendations (1)

NICE issued a Do Not Do Recommendation in June 2006 (updated July 2017) which states:

"Acute levodopa and apomorphine challenge tests should not be used in the differential diagnosis of parkinsonian syndromes."